Olopatadine HCL 0.1% eye drops 5ML
Ended Awarded
- Contract number
- SPE2DB25FW8X1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,399
Award facts
- Contract value 100% obligated
- $2,398.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units, with a ceiling value of $2,398.95. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and was awarded on September 5, 2025. The contract represents a non-set-aside award under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, positioning AmerisourceBergen to fulfill diverse pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FW8X1?
SPE2DB25FW8X1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FW8X1 worth?
The government has obligated $2,399 on SPE2DB25FW8X1.
Is contract SPE2DB25FW8X1 an order under another contract?
Yes. SPE2DB25FW8X1 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB25FW8X1 competed?
The extent of competition for SPE2DB25FW8X1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award